NYSE: JNJJohnson & Johnson Stock Ownership - Who owns Johnson & Johnson?
Insider buying vs selling
Have Johnson & Johnson insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert J. Decker | VP Corporate Controller | 2024-08-30 | 5,635 | $165.06 | $930.11kSell |
| Robert J. Decker | VP Corporate Controller | 2024-08-30 | 5,635 | $100.06 | $563.84kBuy |
| Vanessa Broadhurst | EVP Global Corp Affairs | 2024-07-08 | 5,018 | $147.16 | $738.45kSell |
| John C. 1. Reed | EVP Innovative Medicine RD | 2024-05-01 | 10,984 | $144.59 | $1.59MSell |
| Vanessa Broadhurst | EVP Global Corp Affairs | 2024-03-13 | 8,891 | $162.16 | $1.44MSell |
| William Hait | Officer | 2024-02-13 | 427 | $157.85 | $67.40kSell |
| Timothy Schmid | EVP WW Chair MedTech | 2024-02-13 | 250 | $157.85 | $39.46kSell |
| Vanessa Broadhurst | EVP Global Corp Affairs | 2024-02-13 | 209 | $157.85 | $32.99kSell |
| Joseph J. Wolk | Exec VP CFO | 2024-02-13 | 773 | $157.85 | $122.02kSell |
| Joaquin Duato | CEO and Chairman of the Board | 2024-02-13 | 1,507 | $157.85 | $237.88kSell |
JNJ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when JNJ insiders and whales buy or sell their stock.
JNJ Shareholders
What type of owners hold Johnson & Johnson stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 9.51% | 229,041,796 | $36.98B | Institution |
| Blackrock Inc | 8.23% | 198,186,824 | $32.00B | Institution |
| State Street Corp | 5.53% | 133,091,723 | $21.49B | Institution |
| Geode Capital Management LLC | 2.29% | 55,102,121 | $8.90B | Institution |
| Morgan Stanley | 1.75% | 42,069,269 | $6.79B | Institution |
| State Farm Mutual Automobile Insurance Co | 1.32% | 31,675,492 | $5.11B | Institution |
| Jpmorgan Chase Co | 1.23% | 29,583,659 | $4.78B | Institution |
| Norges Bank | 1.21% | 29,092,369 | $4.70B | Institution |
| Northern Trust Corp | 1.18% | 28,430,009 | $4.59B | Institution |
| Price T Rowe Associates Inc | 1.03% | 24,909,195 | $4.02B | Institution |
JNJ vs General Drug Manufacturer Stocks
Johnson & Johnson Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.